1. Home
  2. BRID vs STRO Comparison

BRID vs STRO Comparison

Compare BRID & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • STRO
  • Stock Information
  • Founded
  • BRID 1932
  • STRO 2003
  • Country
  • BRID United States
  • STRO United States
  • Employees
  • BRID N/A
  • STRO N/A
  • Industry
  • BRID Specialty Foods
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BRID Consumer Staples
  • STRO Health Care
  • Exchange
  • BRID Nasdaq
  • STRO Nasdaq
  • Market Cap
  • BRID 70.3M
  • STRO 77.7M
  • IPO Year
  • BRID N/A
  • STRO 2018
  • Fundamental
  • Price
  • BRID N/A
  • STRO $0.76
  • Analyst Decision
  • BRID
  • STRO Hold
  • Analyst Count
  • BRID 0
  • STRO 7
  • Target Price
  • BRID N/A
  • STRO $3.97
  • AVG Volume (30 Days)
  • BRID 5.5K
  • STRO 1.4M
  • Earning Date
  • BRID 08-22-2025
  • STRO 08-12-2025
  • Dividend Yield
  • BRID N/A
  • STRO N/A
  • EPS Growth
  • BRID N/A
  • STRO N/A
  • EPS
  • BRID N/A
  • STRO N/A
  • Revenue
  • BRID $224,673,000.00
  • STRO $66,434,000.00
  • Revenue This Year
  • BRID N/A
  • STRO N/A
  • Revenue Next Year
  • BRID N/A
  • STRO N/A
  • P/E Ratio
  • BRID N/A
  • STRO N/A
  • Revenue Growth
  • BRID N/A
  • STRO N/A
  • 52 Week Low
  • BRID $7.50
  • STRO $0.52
  • 52 Week High
  • BRID $14.69
  • STRO $5.17
  • Technical
  • Relative Strength Index (RSI)
  • BRID 50.67
  • STRO 44.92
  • Support Level
  • BRID $7.78
  • STRO $0.67
  • Resistance Level
  • BRID $8.74
  • STRO $0.79
  • Average True Range (ATR)
  • BRID 0.22
  • STRO 0.07
  • MACD
  • BRID 0.01
  • STRO -0.01
  • Stochastic Oscillator
  • BRID 34.68
  • STRO 34.52

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: